Literature DB >> 8453581

Stage at presentation and survival of white and black patients with prostate carcinoma.

P N Brawn1, E H Johnson, D L Kuhl, M W Riggs, V O Speights, C F Johnson, P P Pandya, M L Lind, N F Bell.   

Abstract

BACKGROUND: Black men are known to have a higher incidence and mortality from prostate carcinoma than white men and are more likely to have a more advanced stage or grade of disease diagnosed.
METHODS: In a Veterans Administration Medical Center where black and white men have the same eligibility for medical care, the authors reviewed the stage at presentation of 861 consecutive cases of prostate carcinoma diagnosed from 1969-1990. In addition, survival, stratified by race, stage, and grade, was determined on all men in whom prostate cancer was diagnosed from 1969-1985 (525 patients).
RESULTS: It was found that 26% of white and 52% of black men with prostate carcinoma presented with Stage D disease. Similar proportions of white and black men with prostate carcinoma presented with Stage D disease between 1969-73 as between 1986-90. The overall survival was poorer for black men because of their higher proportion of Stage D disease, but stratified for grade and stage, survival was similar in both races.
CONCLUSIONS: This study suggests that factors other than eligibility for medical care may be responsible for the higher proportion of black men with prostate carcinoma presenting with Stage D prostate carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8453581     DOI: 10.1002/1097-0142(19930415)71:8<2569::aid-cncr2820710822>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Authors:  C A Pettaway
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

Review 2.  Prostate cancer detection strategies.

Authors:  Timothy C Brand; Javier Hernandez; Edith D Canby-Hagino; Joseph W Basler; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 3.092

3.  Keynote address: prostate cancer among African-American men--from the bench to the community.

Authors:  I Powell
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

4.  Redefining hormone resistance in prostate cancer.

Authors:  Christopher J Hoimes; W Kevin Kelly
Journal:  Ther Adv Med Oncol       Date:  2010-03-01       Impact factor: 8.168

5.  Prostate cancer cognitive-behavioral factors in a West African population.

Authors:  Folakemi T Odedina; Daohai Yu; Titilola O Akinremi; R Renee Reams; Matthew L Freedman; Nagi Kumar
Journal:  J Immigr Minor Health       Date:  2008-12-04

6.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Authors:  Evelyn C Y Chan; Sally W Vernon; Frederick T O'Donnell; Chul Ahn; Anthony Greisinger; Donnie W Aga
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

7.  Radical prostatectomy: lower rates among African-American men.

Authors:  P J Imperato; R P Nenner; T O Will
Journal:  J Natl Med Assoc       Date:  1996-09       Impact factor: 1.798

8.  Contemporary risk profile of prostate cancer in the United States.

Authors:  Yu-Hsuan Shao; Kitaw Demissie; Weichung Shih; Amit R Mehta; Mark N Stein; Calpurnyia B Roberts; Robert S Dipaola; Grace L Lu-Yao
Journal:  J Natl Cancer Inst       Date:  2009-08-27       Impact factor: 13.506

9.  A focus group study of factors influencing African-American men's prostate cancer screening behavior.

Authors:  Folakemi T Odedina; John Scrivens; Angela Emanuel; Margareth LaRose-Pierre; James Brown; Rowena Nash
Journal:  J Natl Med Assoc       Date:  2004-06       Impact factor: 1.798

10.  Surgical versus medical castration in the Bahamas: a male macho paradox.

Authors:  Robin Roberts
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.